CRISPR Medicine News

CRISPR Medicine News

ARCUS Gene Editor Shows Promise Against Hepatitis...

Precision BioSciences presented encouraging early clinical results from its PBGENE-HBV programme at...

CRISPR exposes ageing and mitotic stress in GATA2...

Researchers in Spain have used CRISPR-Cas9 to engineer human cord blood CD34⁺ HSPCs to model the...

Our pick

Highlight: HiFiCas9 Selectively Disables Mutant...

Spanish researchers have developed a CRISPR-CAS High Fidelity system that specifically targets G12C and G12D mutations in non-small cell lung cancer....

Business News

Press Release Service

Vertex Announces CASGEVY® Reimbursement Agreement...

Press Release Service

Pencil Biosciences Appoints Jonathan Thon, PhD, as...

Press Release Service

Seek Labs Maps Foot-and-Mouth Disease with...

Press Release Service

Scribe Therapeutics Highlights Latest Data on...

CMN Weekly (12 September 2025) - Your Weekly...

Some of the best links we picked up around the internet

eGenesis Receives FDA Clearance for Gene-Edited...

eGenesis announced on Monday that the US FDA has cleared its IND application for EGEN-2784, a...

TIGER Reporter Mouse Facilitates Evaluation of...

Researchers at various institutes in the United States have developed the TIGER mouse model that...

CMN Weekly (5 September 2025) - Your Weekly CRISPR...

Some of the best links we picked up around the internet

Highlight: HiFiCas9 Selectively Disables Mutant...

Spanish researchers have developed a CRISPR-CAS High Fidelity system that specifically targets G12C...

CMN Weekly (29 August 2025) - Your Weekly CRISPR...

Some of the best links we picked up around the internet

Webinar

PRCSR CRISPR: Vivlion's CRISPR-enabled Discovery...

Webinar | Wednesday December 6, 2023 | 3:00 pm–4:30 pm CET / 9:00 am–10:30 am EDT

Webinar

CRISPR Helps Decode the Epigenetic Mysteries of...

Webinar | Wednesday November 22, 2023 | 3:00 pm–4:00 pm CET / 9:00 am–10:00 am EDT

Axelyf advances potent RNA delivery platform

Axelyf, a biotechnology company focused on RNA therapeutics, has secured $2.6 million in seed...

CMN Weekly (22 August 2025) - Your Weekly CRISPR...

Some of the best links we picked up around the internet

Prime editing corrects G6PD deficiency in stem...

A plasmid-delivered prime editing strategy corrected the glucose-6-phosphate dehydrogenase (G6PD)...

CMN Weekly (15 August 2025) - Your Weekly CRISPR...

Some of the best links we picked up around the internet

Recent Clinical Trial Updates from CRISPR Medicine...

The latest clinical update includes dosing announcements for two trials, with the first patients now...

CMN Weekly (8 August 2025) - Your Weekly CRISPR...

Some of the best links we picked up around the internet

New Partnership Announcement: CMN x EDUGENE

We’re excited to announce a strategic partnership between CRISPR Medicine News (CMN) and EDUGENE -...

CRISPR-Edited Beta Cells Avoid Immune Rejection...

CRISPR-Cas12b technology was used to edit allogeneic donor islet cells for transplantation into a...

CMN Weekly (1 August 2025) - Your Weekly CRISPR...

Some of the best links we picked up around the internet

YOLT-203 Awarded EMA Orphan Drug Designation for...

YolTech Therapeutics announced earlier this week that the European Medicines Agency has granted...

CMN Weekly (25 July 2025) - Your Weekly CRISPR...

Some of the best links we picked up around the internet

Extended: CRISPR does not drive resistance in HIV...

Building on prior work demonstrating HIV-1 elimination using dual CRISPR-Cas9 editing and...

CMN Weekly (18 July 2025) - Your Weekly CRISPR...

Some of the best links we picked up around the internet

Clinical Update: YolTech's Base-Editing Therapy...

YolTech Therapeutics announced on Monday that the Chinese National Medical Products Administration...

CMN Weekly (11 July 2025) - Your Weekly CRISPR...

Some of the best links we picked up around the internet

CRISPR editors gain precision via evolved hotspots

CRISPR cytosine base editors have been refined through directed evolution of enzyme recognition...

CMN Weekly (4 July 2025) - Your Weekly CRISPR...

Some of the best links we picked up around the internet

Breaking: CRISPR screen identifies endosomal...

A comprehensive CRISPR-CAS whole-genome screen has revealed key proteins controlling anti-sense...

CMN Weekly (27 June 2025) - Your Weekly CRISPR...

Some of the best links we picked up around the internet

Tamoxifen controls gene activation with CRISPRa/i

A tamoxifen-inducible CRISPRa/i system has been developed to enable reversible and rapid control of...

Silent mutations alter cell fitness in humans, PE...

A high-throughput prime editing screen in human cells reveals that some synonymous mutations, long...

CMN Weekly (20 June 2025) - Your Weekly CRISPR...

Some of the best links we picked up around the internet

Intellia Reports Positive Three-Year Follow-up...

Intellia Therapeutics has reported positive three-year follow-data from the ongoing Phase 1/2 trial...

Eli Lilly to Acquire Verve Therapeutics to Advance...

Eli Lilly announced today that it will acquire Verve Therapeutics for up to $1.3 billion to develop...

Hydrogel enhances CRISPR-mediated tumour targeting

Chinese researchers have developed a thermosensitive, polyamine-modified hydrogel that significantly...

CMN Weekly (13 June 2025) - Your Weekly CRISPR...

Some of the best links we picked up around the internet

First cancer patient dosed in CRISPR-armed phage...

SNIPR Biome has dosed the first patient in its Phase 1b trial of SNIPR001, a CRISPR-CAS-armed...

Deep learning predicts CRISPR off-target effects

A new computational framework called CCLMoff uses deep learning and RNA language models to predict...

Modalis Partners with SOLVE FSHD to Develop CRISPR...

Modalis Therapeutics has partnered with SOLVE FSHD to advance the development of an experimental...

CMN Weekly (6 June 2025) - Your Weekly CRISPR...

Some of the best links we picked up around the internet

CRISPR-Cas9 Screens Uncover NR2F2 as a Key...

Using CRISPR-Cas9 screens, researchers in the United States, Belgium and China have identified NR2F2...

Allogene Therapeutics' ALLO-316 Shows Durable...

New clinical data from Allogene Therapeutics' Phase 1 TRAVERSE trial reveals durable responses in...

Breaking: CRISPR-CAS13 enables programmable RNA...

Today, researchers in researchers in South Korea announced a method to selectively install...

CMN Weekly (30 May 2025) - Your Weekly CRISPR...

Some of the best links we picked up around the internet

CRISPR-Mediated Removal of Mutated COL7A1 Exons...

Researchers in Spain and Germany report using CRISPR-mediated exon removal to restore collagen...

Base editors reshape pathogenic repeats

Researchers have developed a CRISPR-CAS base editing approach to treat trinucleotide repeat...

CARBON Newsletter (27 May 2025) - Your Latest News...

Some of the best links we picked up around the internet

CMN Weekly (23 May 2025) - Your Weekly CRISPR...

Some of the best links we picked up around the internet

About CRISPR Medicine News

Welcome to CRISPR Medicine News.
We are a global independent online media writing about gene therapy and genome editing.

Learn - Innovate - Access

CLINICAL TRIALS

Ovarian Cancer, OC, (NCT06846424)
Sponsors:
Shanghai Gynecologic Oncology Group

IND Enabling

Phase I

Phase II

Phase III

Malaria Infection, (NCT06881732)
Sponsors:
University of Melbourne

IND Enabling

Phase I

Phase II

Phase III

Liver Transplant, (NCT07053488)
Sponsors:
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC

IND Enabling

Phase I

Phase II

Phase III

View all clinical trials

CRISPR Medicine News

Harvard Medical School (@HMS)

Genome Engineering Seminar Series (GESS)

Harvard Medical School (@HMS)

Join WDC Chat Community — WDC Chat Community

MOST READ

CRISPRMED24 is a wrap, and here's to...

Therapeutic Gene Editing. A Lot Done, a Lot More...

Clinical Highlights From the Gene-Editing Field in...

RSS

Subscribe to this feed

Search CRISPR Medicine